AU2002228911A1 - Methods for inhibiting pain - Google Patents
Methods for inhibiting painInfo
- Publication number
- AU2002228911A1 AU2002228911A1 AU2002228911A AU2891102A AU2002228911A1 AU 2002228911 A1 AU2002228911 A1 AU 2002228911A1 AU 2002228911 A AU2002228911 A AU 2002228911A AU 2891102 A AU2891102 A AU 2891102A AU 2002228911 A1 AU2002228911 A1 AU 2002228911A1
- Authority
- AU
- Australia
- Prior art keywords
- methods
- inhibiting pain
- pain
- inhibiting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/545—IL-1
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70837500A | 2000-11-08 | 2000-11-08 | |
US09/708,375 | 2000-11-08 | ||
PCT/US2001/047419 WO2002038035A2 (en) | 2000-11-08 | 2001-11-08 | Methods for inhibiting pain |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002228911A1 true AU2002228911A1 (en) | 2002-05-21 |
Family
ID=24845553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002228911A Abandoned AU2002228911A1 (en) | 2000-11-08 | 2001-11-08 | Methods for inhibiting pain |
Country Status (5)
Country | Link |
---|---|
US (1) | US20080026003A1 (en) |
EP (1) | EP1361897A4 (en) |
JP (1) | JP2004537497A (en) |
AU (1) | AU2002228911A1 (en) |
WO (1) | WO2002038035A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR035971A1 (en) | 2001-05-16 | 2004-07-28 | Cephalon Inc | METHODS FOR THE TREATMENT AND PREVENTION OF PAIN |
US20060253100A1 (en) | 2004-10-22 | 2006-11-09 | Medtronic, Inc. | Systems and Methods to Treat Pain Locally |
USRE48948E1 (en) | 2008-04-18 | 2022-03-01 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable polymer |
US20100239632A1 (en) | 2009-03-23 | 2010-09-23 | Warsaw Orthopedic, Inc. | Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0570462A4 (en) * | 1991-02-05 | 1994-11-23 | Univ Maryland | MODIFIED INTERLEUKIN-1-g(b). |
JP3957740B2 (en) * | 1992-06-01 | 2007-08-15 | カイロン コーポレイション | Methods of using lipoprotein-related aggregation inhibitors to treat sepsis |
US6048850A (en) * | 1992-09-22 | 2000-04-11 | Young; Donald A. | Method of inhibiting prostaglandin synthesis in a human host |
US6492332B1 (en) * | 1995-12-12 | 2002-12-10 | Omeros Corporation | Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation |
US6096753A (en) * | 1996-12-05 | 2000-08-01 | Amgen Inc. | Substituted pyrimidinone and pyridone compounds and methods of use |
-
2001
- 2001-11-08 JP JP2002540626A patent/JP2004537497A/en not_active Withdrawn
- 2001-11-08 AU AU2002228911A patent/AU2002228911A1/en not_active Abandoned
- 2001-11-08 EP EP01990036A patent/EP1361897A4/en not_active Withdrawn
- 2001-11-08 WO PCT/US2001/047419 patent/WO2002038035A2/en not_active Application Discontinuation
-
2007
- 2007-01-04 US US11/649,475 patent/US20080026003A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002038035A2 (en) | 2002-05-16 |
EP1361897A2 (en) | 2003-11-19 |
US20080026003A1 (en) | 2008-01-31 |
JP2004537497A (en) | 2004-12-16 |
EP1361897A4 (en) | 2004-10-13 |
WO2002038035A3 (en) | 2002-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001258771A1 (en) | -secretase inhibitors | |
AU2002223827A1 (en) | Well treatment | |
AU2002222853A1 (en) | Therapeutic compounds | |
AU2002215125A1 (en) | Well treatment method | |
AU2001254546A1 (en) | Aminopiperidines | |
AU2000267458A1 (en) | Hypercomputer | |
AU2001280599A1 (en) | Compounds and methods | |
AU2001253418A1 (en) | Compounds and methods | |
AU2001239310A1 (en) | Decahydro-isoquinolines | |
AU2001220246A1 (en) | Neckphone | |
AU2001243394A1 (en) | Compounds and methods | |
AU2001285886A1 (en) | 2-guanidino-4-aryl-quinazoline | |
AU2608301A (en) | Methods for inhibiting mastocytosis | |
AU2001220281A1 (en) | Rollerboard for road-skiing | |
AUPQ872300A0 (en) | Compounds and methods | |
AU2001240557A1 (en) | Implant for cranioplastics | |
AU2001266176A1 (en) | Methods | |
AU2001237530A1 (en) | Method | |
AU2001278951A1 (en) | Compounds and methods | |
AU2001246864A1 (en) | Hypotensors | |
AU2001231107A1 (en) | Improved lactational | |
AU2002214354A1 (en) | Neck-phone | |
AU2002228911A1 (en) | Methods for inhibiting pain | |
AU2001241636A1 (en) | Halotherapy method | |
AU2001250536A1 (en) | Methods |